3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
4
Venous Thrombosis
2
Pulmonary Embolism
2
Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Thrombosis
1
Thromboembolism
1
Sarcoma
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
apixaban
3
Warfarin
2
Dalteparin
2
Aspirin
2
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
Simvastatin
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Paclitaxel
1
Observation
1
Injections
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Data Collection
1
Dabigatran
1
Clopidogrel
1
Arginine Vasopressin
1
Arginine
1
Anticoagulants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombosis
×
Fondaparinux
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts